Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: First identification of KPC-2 or NDM-1-producing E. coli in Taiwan

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Ma, Ling ^a   Siu, L Kristopher ^a   Lin, Jung Chung ^b   Wu, Tsu Lan ^c   Fung, Chang Phone ^d   Wang, Jann Tay ^e   Lu, Po Liang ^f,g   Chuang, Yin Ching ^h  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^h CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; CARBAPENEMASE; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA LACTAMASE KPC 2; BETA LACTAMASE NDM 1; BETA-LACTAMASE KPC-2; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARBAPENEM NON SUSCEPTIBLE ESCHERICHIA COLI; CLONAL VARIATION; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC CODE; INFECTION CONTROL; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; TAIWAN;

EID: 84890456897     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-599     Document Type: Article

References (39)

1. Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y: Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrob Agents Chemother 2010, 54(6):2687-2691
2. Schwaber MJ, Carmeli Y: Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 2008, 300(24):2911-2913
3. Patel JB, Rasheed JK, Kitchel B: Carbapenemases in Enterobacteriaceae: activity, epidemiology, and laboratory detection. Clin Microbiol Newsl 2009, 31(8):55-62
4. Queenan AM, Bush K: Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007, 20(3):440-458
5. Poirel L, Heritier C, Spicq C, Nordmann P: In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 2004, 42(8):3831-3833
6. Stapleton PD, Shannon KP, French GL: Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999, 43(5):1206-1210
7. Goessens WH, van der Bij AK, van Boxtel R, Pitout JD, van Ulsen P, Melles DC, Tommassen J: Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli. Antimicrob Agents Chemother 2013, 57(8):3941-3949
8. Patel G, Bonomo RA: "Stormy waters ahead": global emergence of carbapenemases. Front Microbiol 2013, 4:48
9. Livermore DM: Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012, 27(2):128-142
10. Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y: Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006, 50(9):3098-3101
11. Nordmann P, Poirel L: Emerging carbapenemases in gram-negative aerobes. Clin Microbiol Infect 2002, 8(6):321-331
12. Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D, Quale J: Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis 2007, 44(7):972-975
13. Rogers BA, Sidjabat HE, Paterson DL: Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66(1):1-14
14. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Second informational supplement. CLSI M100-S22-U. Wayne, PA; 2011
15. Clinical and Laboratory Standards Institute: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved standard Ninth Edition. Wayne, PA; 2012
16. Alvarez M, Tran JH, Chow N, Jacoby GA: Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob Agents Chemother 2004, 48(2):533-537
17. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, et al: Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004, 48(4):1249-1255
18. D'Agata EM, Gerrits MM, Tang YW, Samore M, Kusters JG: Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol 2001, 22(9):550-554
19. Freire P, Vieira HL, Furtado AR, de Pedro MA, Arraiano CM: Effect of the morphogene bolA on the permeability of the Escherichia coli outer membrane. FEMS Microbiol Lett 2006, 260(1):106-111
20. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, et al: Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006, 60(5):1136-1151
21. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ: Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007, 51(2):763-765
22. Cai JC, Zhou HW, Zhang R, Chen GX: Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008, 52(6):2014-2018
23. Nordmann P, Cuzon G, Naas T: The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009, 9(4):228-236
24. Chung KP, Tseng SP, Huang YT, Tsai TH, Teng LJ, Hsueh PR: Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. J Antimicrob Chemother 2011, 66(5):1182-1184
25. Lauderdale TL, Shi ZY, Lin CF, Lai JF, Tan MC, Wang JT, Chang SC: KPC-2-producing sequence type 11 Klebsiella pneumoniae detected in Taiwan. Antimicrob Agents Chemother 2012, 56(4):2207-2208
26. Chiu SK, Wu TL, Chuang YC, Lin JC, Fung CP, Lu PL, Wang JT, Wang LS, Siu LK, Yeh KM: National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One 2013, 8(7):e69428
27. Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, Doi Y: Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin Infect Dis 2012, 55(2):224-231
28. D'Alincourt Carvalho-Assef AP, Leao RS, da Silva RV, Ferreira AG, Seki LM, Asensi MD, Marques EA: Escherichia coli producing KPC-2 carbapenemase: first report in Brazil. Diagn Microbiol Infect Dis 2010, 68(3):337-338
29. Mavroidi A, Miriagou V, Malli E, Stefos A, Dalekos GN, Tzouvelekis LS, Petinaki E: Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 beta-lactamase. Int J Antimicrob Agents 2012, 39(3):247-250
30. Morris D, Boyle F, Ludden C, Condon I, Hale J, O'Connell N, Power L, Boo TW, Dhanji H, Lavallee C, et al: Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 2011, 55(10):4935-4936
31. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P: When carbapenemhydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France. Antimicrob Agents Chemother 2011, 55(10):4933-4934
32. Bercot B, Poirel L, Nordmann P: Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers. Diagn Microbiol Infect Dis 2011, 71(4):442-445
33. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE: Early dissemination of NDM-1-and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011, 55(3):1274-1278
34. Mushtaq S, Irfan S, Sarma JB, Doumith M, Pike R, Pitout J, Livermore DM, Woodford N: Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 2011, 66(9):2002-2005
35. Wu TL, Chia JH, Su LH, Chiu CH, Kuo AJ, Ma L, Siu LK: CMY-2 betalactamase-carrying community-acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Choleraesuis and Typhimurium. Int J Antimicrob Agents 2007, 29(4):410-416
36. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P: Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008, 14(2):195-200
37. Peirano G, Pitout JD: Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010, 35(4):316-321
38. Doi Y, Arakawa Y: 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 2007, 45(1):88-94
39. Ma L, Lin CJ, Chen JH, Fung CP, Chang FY, Lai YK, Lin JC, Siu LK: Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2009, 53(1):104-111